| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T17 |
0-88 |
Sentence |
denotes |
2 Autoimmune diseases / syndromes potentially associated with Covid-19 described so far |
| T18 |
89-466 |
Sentence |
denotes |
It has been suggested that the shared pathogenetic mechanisms and clinical-radiological aspects between the hyper-inflammatory diseases and Covid-19 may suggest that SARS-CoV-2 could act as a triggering factor for the development of a rapid autoimmune and/or autoinflammatory dysregulation, leading to the severe interstitial pneumonia, in genetic predisposed individuals [26]. |
| T19 |
467-667 |
Sentence |
denotes |
Furthermore, in an online pre-published study from Germany the authors studied prospectively a group of 22 patients for the possible role of autoimmunity in SARS-CoV-2 -associated respiratory failure. |
| T20 |
668-998 |
Sentence |
denotes |
Based on serological, radiological and histomorphological similarities between Covid-19-associated ARDS and acute exacerbation of connective tissue disease induced interstitial lung disease, the authors suggest that SARS-CoV-2 infection might trigger or simulate a form of organ specific autoimmunity in predisposed patients [27]. |
| T21 |
999-1270 |
Sentence |
denotes |
In a similar retrospective study from China of 21 patients with critical SARS-CoV-2 pneumonia, the authors showed a prevalence of between 20 and 50% of autoimmune disease related autoantibodies, suggesting the rational for immunosupression in such cases of Covid-19 [28]. |
